An interventional study of Tooth varnish (PRG Barrier Coat from Shofu) and Tooth varnish (Clinpro white varnish 3M) in Dentin Hypersensitivity, sponsored by Eman Omar Elfarouk. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-26.
Sponsored by Eman Omar Elfarouk · Not applicable, Interventional, and Treatment
Among 33 studies in Dentin Sensitivity with a site in Egypt — 6 open to participants now, 8 under way, 1 of them phase 3. Dentin Sensitivity · Egypt.
Among the 33 studies in Dentin Sensitivity with a site in Egypt, this one is the 13th largest by planned enrollment of the 32 interventional ones, is one of 8 that started in 2024, is one of 24 with no phase, and was the 16th registered.
288 studies on the registry are indexed under Dentin Sensitivity; 46 are open to participants now.
This study's planned enrollment of 50 is below the median of 60 across 279 interventional studies indexed under Dentin Sensitivity.
Browse Dentin Sensitivity studies →6 of the 33 studies in Dentin Sensitivity with a site in Egypt are open now, in 1 country. Each count lists the studies.
Of the 18 Dentin Sensitivity studies recruiting now, 6 (33%) set no upper age limit and 11 (61%) stop at 75 or younger; 1 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →33 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 8 started in 2024.
Median enrollment 48 across the 32 interventional studies, 500 across the 1 observational. Of the 20 that completed or were terminated, 0 (0%) have results posted.
1 of 33 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Eman Omar Elfarouk as lead sponsor.
Eman Omar Elfarouk has 1 study filed under Dentin Sensitivity — fewer than ten, so there is no comparison to draw.
1 of the studies in Dentin Sensitivity with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06772051Mansoura UniversityClinical Evaluation of Short Dentin Etching | 2026-12-24 |
Among the 33 studies in Dentin Sensitivity with a site in Egypt, from their registry updates:
The goal of this clinical trial is to compare the effect of desensitizer containing S-PRG have similar effect as sodium fluoride with functionalized tri-calcium phosphate containing desensitizer in relieving dentinal hypersensitivity in adult patients for six months follow-up. patients will be asked to report pain degree on the visual analogue scale (VAS) along the follow up periods on both groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Treatment of dentin hypersensitivity by application of tooth varnish containing S-PRG.
Procedure: Tooth varnish (PRG Barrier Coat from Shofu)
Treatment of dentin hypersensitivity by application of tooth varnish containing sodium fluoride with functionalized tri-calcium phosphate.
Procedure: Tooth varnish (Clinpro white varnish 3M)
Treatment of cervical dentin hypersensitivity with tooth desensitizers.
Treatment of cervical dentin hypersensitivity with tooth desensitizers.
Dentin hypersensitivity reduction
The participants will point out the degree of sensitivity on the VAS scale (0-10) chart.
Time frame: assessment will be done immediately after the treatment then after 1 week, 4 weeks, 3 months and 6 months.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for May 2024; primary completion for Nov 2024, 6 months later.
Of 111 non-industry interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 12. This study's planned 6 months is below that.
Counting every sponsor, half of 144 studies reached it within 6 months; a quarter within 3 and three quarters within 10.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.